研究業績

  1. ホーム
  2. 業績
  3. 研究業績
  4. 2022年
  1. 2023年
  2. 2022年
  3. 2021年
  4. 2020年
  5. 2019年
  6. 2018年
  7. 2017年
  8. 2016年
  9. 2015年
  10. 2014年
  11. 2013年
  12. 2012年
  13. 2011年
  14. 2010年
  15. 2009年
  16. 2008年
  17. 2007年
  18. 2006年
  19. 2005年
  20. 2004年

2022年研究業績

英文総説

  1. Varelias A, Zhang P, Hashimoto D. Editorial: Mouse Models of Hematopoietic Stem Cell Transplantation Front Immunol. 2022 Apr 6;13:882592. doi: 10.3389/fimmu.2022.882592. eCollection 2022. PMID : 35464393
  2. Hashimoto D. Guest editorial: prophylaxis and treatment of relapse after allogeneic hematopoietic stem cell transplantation Int J Hematol. 2022 Sep;116(3):307-308. doi: 10.1007/s12185-022-03407-8. Epub 2022 Jul 11. PMID : 35821549

英文原著

  1. Shouval R, Waters NR, Gomes ALC, Zuanelli Brambilla C, Fei T, Devlin SM, Nguyen CL, Markey KA, Dai A, Slingerland JB, Clurman AG, Fontana E, Amoretti LA, Wright RJ, Hohl TM, Taur Y, Sung AD, Weber D, Hashimoto D, Teshima T, Chao NJ, Holler E, Scordo M, Giralt SA, Perales MA, Peled JU, van den Brink MRM. Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell Transplantation Clin Cancer Res. 2023 Jan 4;29(1):165-173. doi: 10.1158/1078-0432.CCR-22-1254. PMID : 36322005
  2. Kuno M, Yamasaki S, Fujii N, Ishida Y, Fukuda T, Kataoka K, Uchida N, Katayama Y, Sato M, Onai D, Miyamoto T, Ota S, Yoshioka S, Ara T, Hangaishi A, Hashii Y, Onizuka M, Ichinohe T, Atsuta Y, Inamoto Y; on behalf of the Japan Society for Hematopoietic Cell Transplantation Late Effects and Quality of Life Working Group. Characterization of myeloid neoplasms following allogeneic hematopoietic cell transplantation Am J Hematol. 2022 Feb 1;97(2):185-193. doi: 10.1002/ajh.26401. Epub 2021 Nov 16. PMID : 34738245
  3. Fuji S, Hirakawa T, Takano K, Doki N, Sawa M, Kanda Y, Uchida N, Ara T, Miyamoto T, Eto T, Matsuoka KI, Kawakita T, Ozawa Y, Katayama Y, Onizuka M, Fukuda T, Atsuta Y, Nakasone H. Disease-specific impact of anti-thymocyte globulin in allogeneic hematopoietic cell transplantation: a nationwide retrospective study on behalf of the JSTCT, transplant complications working group Bone Marrow Transplant. 2022 Mar;57(3):479-486. doi: 10.1038/s41409-022-01569-x. Epub 2022 Jan 17. PMID : 35039621
  4. Iwasaki M, Kanda J, Tanaka H, Shindo T, Sato T, Doki N, Fukuda T, Ozawa Y, Eto T, Uchida N, Katayama Y, Kataoka K, Ara T, Ota S, Onizuka M, Kanda Y, Ichinohe T, Atsuta Y, Morishima S. Impact of HLA Epitope Matching on Outcomes After Unrelated Bone Marrow Transplantation Front Immunol. 2022 Mar 3;13:811733. doi: 10.3389/fimmu.2022.811733. eCollection 2022. PMID : 35309307
  5. Ishio T, Kumar S, Shimono J, Daenthanasanmak A, Dubois S, Lin Y, Bryant B, Petrus MN, Bachy E, Huang DW, Yang Y, Green PL, Hasegawa H, Maeda M, Goto H, Endo T, Yokota T, Hatanaka KC, Hatanaka Y, Tanaka S, Matsuno Y, Yang Y, Hashino S, Teshima T, Waldmann TA, Staudt LM, Nakagawa M. Genome-wide CRISPR screen identifies CDK6 as a therapeutic target in adult T-cell leukemia/lymphoma Blood. 2022 Mar 10;139(10):1541-1556. doi: 10.1182/blood.2021012734. PMID : 34818414
  6. Tamaki M, Kameda K, Kimura SI, Harada N, Uchida N, Doki N, Tanaka M, Ikegame K, Sawa M, Katayama Y, Miyakoshi S, Ara T, Kanda J, Onizuka M, Fukuda T, Atsuta Y, Kanda Y, Yakushijin K, Nakasone H. Deletion of Y chromosome before allogeneic hematopoietic stem cell transplantation in male recipients with female donors Blood Adv. 2022 Mar 22;6(6):1895-1903. doi: 10.1182/bloodadvances.2021006456. PMID : 35108728
  7. Kimura SI, Kameda K, Harada K, Saburi M, Okinaka K, Shinohara A, Uchida N, Nishijima A, Ozawa Y, Tanaka M, Kuriyama T, Katayama Y, Sawa M, Ikegame K, Kawakita T, Kanda Y, Nakamae H, Ara T, Kimura T, Sato A, Fukuda T, Atsuta Y, Nakasone H. Risk and Predictive Factors for Candidemia After Allogeneic Hematopoietic Cell Transplantation: JSTCT Transplant Complications Working Group Transplant Cell Ther. 2022 Apr;28(4):209.e1-209.e9. doi: 10.1016/j.jtct.2021.12.020. Epub 2022 Jan 5. PMID : 34995815
  8. Zhang Z, Hasegawa Y, Hashimoto D, Senjo H, Kikuchi R, Chen X, Yoneda K, Sekiguchi T, Kawase T, Tsuzuki H, Ishio T, Ara T, Ohigashi H, Nakagawa M, Teshima T. Gilteritinib enhances graft-versus-leukemia effects against FLT3-ITD mutant leukemia after allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant. 2022 May;57(5):775-780. doi: 10.1038/s41409-022-01619-4. Epub 2022 Feb 28. PMID : 35228711
  9. Senjo H, Onozawa M, Hidaka D, Yokoyama S, Yamamoto S, Tsutsumi Y, Haseyama Y, Nagashima T, Mori A, Ota S, Sakai H, Ishihara T, Miyagishima T, Kakinoki Y, Kurosawa M, Kobayashi H, Iwasaki H, Hashimoto D, Kondo T, Teshima T. High CRP-albumin ratio predicts poor prognosis in transplant ineligible elderly patients with newly diagnosed acute myeloid leukemia Sci Rep. 2022 May 25;12(1):8885. doi: 10.1038/s41598-022-12813-1. PMID : 35614177
  10. Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Récher C, Yoon SS, Hosono N, Onozawa M, Chiba S, Kim HJ, Hasabou N, Lu Q, Tiu R, Levis MJ. Follow-up of patients with R/R FLT3-mutation-positive AML treated with gilteritinib in the phase 3 ADMIRAL trial Blood. 2022 Jun 9;139(23):3366-3375. doi: 10.1182/blood.2021011583. PMID : 35081255
  11. Goudarzi H, Onozawa M, Takahashi M. Impact of COVID-19 on international medical education and the future plans of medical students in Japan MedEdPublish (2016). 2022 Jun 16;12:15. doi: 10.12688/mep.18953.2. eCollection 2022. PMID : 36168533
  12. Wang ML, Jurczak W, Jerkeman M, Trotman J, Zinzani PL, Belada D, Boccomini C, Flinn IW, Giri P, Goy A, Hamlin PA, Hermine O, Hernández-Rivas JÁ, Hong X, Kim SJ, Lewis D, Mishima Y, Özcan M, Perini GF, Pocock C, Song Y, Spurgeon SE, Storring JM, Walewski J, Zhu J, Qin R, Henninger T, Deshpande S, Howes A, Le Gouill S, Dreyling M; SHINE Investigators. Ibrutinib plus Bendamustine and Rituximab in Untreated Mantle-Cell Lymphoma N Engl J Med. 2022 Jun 30;386(26):2482-2494. doi: 10.1056/NEJMoa2201817. Epub 2022 Jun 3. PMID : 35657079
  13. Yamamoto M, Sato M, Onishi Y, Sasahara Y, Sano H, Masuko M, Nakamae H, Matsuoka KI, Ara T, Washio K, Onizuka M, Watanabe K, Takahashi Y, Hirakawa T, Nishio M, Sakashita C, Kobayashi T, Sawada A, Ichinohe T, Fukuda T, Hashii Y, Atsuta Y, Arai A. Registry data analysis of hematopoietic stem cell transplantation on systemic chronic active Epstein-Barr virus infection patients in Japan Am J Hematol. 2022 Jun 1;97(6):780-790. doi: 10.1002/ajh.26544. Epub 2022 Mar 30. PMID : 35312194
  14. Takamiya S, Kawabori M, Yamazaki K, Yamaguchi S, Tanimori A, Yamamoto K, Ohnishi S, Seki T, Konno K, Tha KK, Hashimoto D, Watanabe M, Houkin K, Fujimura M. Intravenous transplantation of amnion-derived mesenchymal stem cells promotes functional recovery and alleviates intestinal dysfunction after spinal cord injury PLoS One. 2022 Jul 8;17(7):e0270606. doi: 10.1371/journal.pone.0270606. eCollection 2022. PMID : 35802703
  15. Okada Y, Nakasone H, Konuma T, Uchida N, Tanaka M, Sugio Y, Aotsuka N, Nishijima A, Katsuoka Y, Ara T, Ota S, Onizuka M, Sawa M, Kimura T, Fukuda T, Atsuta Y, Kanda J, Kimura F. Ideal Body Weight Is Useful For Predicting Neutrophil Engraftment and Platelet Recovery for Overweight and Obese Recipients in Single-Unit Cord Blood Transplantation Transplant Cell Ther. 2022 Aug;28(8):504.e1-504.e7. doi: 10.1016/j.jtct.2022.05.006. Epub 2022 May 13. PMID : 35577325
  16. Shimazu Y, Murata M, Kondo T, Minami Y, Tachibana T, Doki N, Uchida N, Ozawa Y, Yano S, Fukuda T, Kato J, Ara T, Eto T, Ishikawa J, Nakamae H, Tanaka J, Ichinohe T, Atsuta Y, Nagamura-Inoue T; working group of the Japan Society for Transplantation and Cellular Therapy. The new generation tyrosine kinase inhibitor improves the survival of chronic myeloid leukemia patients after allogeneic stem cell transplantation Hematol Oncol. 2022 Aug;40(3):442-456. doi: 10.1002/hon.3000. Epub 2022 Apr 12. PMID : 35394658
  17. Nishiwaki S, Akahoshi Y, Morita-Fujita M, Shimizu H, Uchida N, Ozawa Y, Fukuda T, Tanaka M, Ikegame K, Ota S, Katayama Y, Takahashi S, Kawakita T, Ara T, Onizuka M, Kimura T, Tanaka J, Atsuta Y, Arai Y. Improvements in allogeneic hematopoietic cell transplantation outcomes for adults with ALL over the past 3 decades Blood Adv. 2022 Aug 9;6(15):4558-4569. doi: 10.1182/bloodadvances.2022008032. PMID : 35737870
  18. Jaeger U, Tam CS, Borchmann P, McGuirk JP, Johansen M, Waller EK, Jaglowski S, Andreadis C, Foley SR, Westin JR, Fleury I, Ho PJ, Mielke S, Teshima T, Salles G, Schuster SJ, He F, Maziarz RT, Mayer S, Makita S, Kersten MJ, Ghosh M, Wagner-Johnston N, Kato K, Corradini P, Goto H, Colicino S, Agarwal A, Lobetti-Bodoni C, Bishop MR. Long-term safety for patients with tisagenlecleucel-treated relapsed/refractory diffuse large B-cell lymphoma Blood Adv. 2022 Aug 23;6(16):4816-4820. doi: 10.1182/bloodadvances.2021006193. PMID : 35687492
  19. Kawagishi N, Suda G, Sakamori R, Matsui T, Onozawa M, Yang Z, Yoshida S, Ohara M, Kimura M, Kubo A, Maehara O, Fu Q, Hosoda S, Tokuchi Y, Suzuki K, Nakai M, Sho T, Morikawa K, Natsuizaka M, Ogawa K, Sakai H, Ohnishi S, Baba M, Takehara T, Sakamoto N. Serum IL-1β predicts de novo hepatitis B virus reactivation during direct-acting antiviral therapy for hepatitis C, not during anti-cancer/immunosuppressive therapy Sci Rep. 2022 Oct 7;12(1):16800. doi: 10.1038/s41598-022-21315-z. PMID : 36207368
  20. Konuma T, Kanda J, Uchida N, Nishijima A, Tanaka M, Ozawa Y, Sawa M, Onizuka M, Ota S, Maruyama Y, Kanda Y, Kawakita T, Ara T, Eto T, Nakamae H, Kimura T, Fukuda T, Atsuta Y; Donor/Source Working Group of theJapanese Society for Transplantation and Cellular Therapy. Intensified conditioning regimens improved disease-free survival and engraftment after unrelated single-unit cord blood transplantation but not after matched sibling or matched unrelated donor allogeneic hematopoietic cell transplantation Hematol Oncol. 2022 Oct 21. doi: 10.1002/hon.3094. Online ahead of print. PMID : 36268564
  21. Mori A, Onozawa M, Kobayashi M, Tsukamoto S, Ishio T, Yokoyama E, Izumiyama K, Saito M, Muraki H, Morioka M, Teshima T, Kondo T. Humoral response to mRNA-based COVID-19 vaccine in patients with de novo and pre-existing immune thrombocytopenia with exacerbation of thrombocytopenia after vaccination Br J Haematol. 2022 Nov;199(4):627-630. doi: 10.1111/bjh.18447. Epub 2022 Sep 12. PMID : 36096497
  22. Buxbaum NP, Socié G, Hill GR, MacDonald KP, Tkachev V, Teshima T, Lee SJ, Ritz J, Sarantopoulos S, Luznik L, Zeng D, Paczesny S, Martin PJ, Pavletic SZ, Schultz KR, Blazar BR. Chronic GvHD NIH Consensus Project Biology Task Force: Evolving path to personalized treatment of chronic GvHD Blood Adv. 2022 Nov 2:bloodadvances.2022007611. doi: 10.1182/bloodadvances.2022007611. Online ahead of print. PMID : 36322878
  23. Nakano K, Sugawa S, Seimiya M, Murakami S, Yasuda K, Watanabe C, Goto H, Teshima T. Frequencies of Anti-Troponin I vs Anti-Troponin T Autoantibodies and Degrees of Interference on Troponin Assays Lab Med. 2022 Nov 2:lmac120. doi: 10.1093/labmed/lmac120. Online ahead of print. PMID : 36322014
  24. Chiba M, Shimono J, Ishio T, Takei N, Kasahara K, Ogasawara R, Ara T, Goto H, Izumiyama K, Otsuguro S, Perera LP, Hasegawa H, Maeda M, Hashino S, Maenaka K, Teshima T, Waldmann TA, Yang Y, Nakagawa M. Genome-wide CRISPR screens identify CD48 defining susceptibility to NK cytotoxicity in peripheral T-cell lymphomas Blood. 2022 Nov 3;140(18):1951-1963. doi: 10.1182/blood.2022015646. PMID : 35921533
  25. Yanagisawa R, Tamaki M, Tanoshima R, Misaki Y, Uchida N, Koi S, Tanaka T, Ozawa Y, Matsuo Y, Tanaka M, Ikegame K, Katayama Y, Matsuoka KI, Ara T, Kanda Y, Matsumoto K, Fukuda T, Atsuta Y, Kato M, Nakasone H. Risk factors for fatal cardiac complications after allogeneic hematopoietic cell transplantation: Japanese Society for Transplantation and Cellular Therapy transplant complications working group Hematol Oncol. 2022 Nov 17. doi: 10.1002/hon.3101. Online ahead of print. PMID : 36385399
  26. Kato K, Fujii N, Makita S, Goto H, Kanda J, Shimada K, Akashi K, Izutsu K, Teshima T, Fukuda N, Sumitani T, Nakamura S, Sumi H, Shimizu S, Kakurai Y, Yoshikawa K, Tobinai K, Usui N, Hatake K. A phase 2 study of axicabtagene ciloleucel in relapsed or refractory large B-cell lymphoma in Japan: 1-year follow-up and biomarker analysis Int J Hematol. 2022 Nov 18. doi: 10.1007/s12185-022-03494-7. Online ahead of print. PMID : 36399286
  27. Yanagisawa R, Hirakawa T, Doki N, Ikegame K, Matsuoka KI, Fukuda T, Nakamae H, Ota S, Hiramoto N, Ishikawa J, Ara T, Tanaka M, Koga Y, Kawakita T, Maruyama Y, Kanda Y, Hino M, Atsuta Y, Yabe H, Tsukada N. Severe short-term adverse events in related bone marrow or peripheral blood stem cell donors Int J Hematol. 2022 Nov 20. doi: 10.1007/s12185-022-03489-4. Online ahead of print. PMID : 36403180
  28. Fukuhara N, Kato K, Goto H, Takeshi T, Kawaguchi M, Tokushige K, Akashi K, Teshima T, Harigae H, Schuster SJ, Thieblemont C, Dreyling M, Fowler N. Efficacy and safety of tisagenlecleucel in adult Japanese patients with relapsed or refractory follicular lymphoma: results from the phase 2 ELARA trial Int J Hematol. 2022 Nov 21. doi: 10.1007/s12185-022-03481-y. Online ahead of print. PMID : 36404384
  29. Mori A, Onozawa M, Kobayashi M, Tsukamoto S, Senjo H, Ishio T, Yokoyama E, Izumiyama K, Saito M, Muraki H, Morioka M, Teshima T, Kondo T. Humoral response to mRNA-based COVID-19 vaccine in patients with immune thrombocytopenia Br J Haematol. 2022 Nov 28. doi: 10.1111/bjh.18578. Online ahead of print. PMID : 36442510
  30. Chen X, Hashimoto D, Ebata K, Takahashi S, Shimizu Y, Shinozaki R, Hasegawa Y, Kikuchi R, Senjo H, Yoneda K, Zhang Z, Harada S, Hayase E, Ara T, Ohigashi H, Iwakura Y, Nakamura K, Ayabe T, Teshima T. Reactive granulopoiesis depends on T-cell production of IL-17A and neutropenia-associated alteration of gut microbiota Proc Natl Acad Sci U S A. 2022 Nov 29;119(48):e2211230119. doi: 10.1073/pnas.2211230119. Epub 2022 Nov 21. PMID : 36409919
  31. Ikezoe T, Ando K, Onozawa M, Yamane T, Hosono N, Morita Y, Kiguchi T, Iwasaki H, Miyamoto T, Matsubara K, Sugimoto S, Miyazaki Y, Kizaki M, Akashi K. Phase I study of alvocidib plus cytarabine/mitoxantrone or cytarabine/daunorubicin for acute myeloid leukemia in Japan Cancer Sci. 2022 Dec;113(12):4258-4266. doi: 10.1111/cas.15458. Epub 2022 Oct 10. PMID : 35689544
  32. Goto H, Izutsu K, Ennishi D, Mishima Y, Makita S, Kato K, Hanaya M, Hirano S, Narushima K, Teshima T, Nagai H, Ishizawa K. Zandelisib (ME-401) in Japanese patients with relapsed or refractory indolent non-Hodgkin's lymphoma: an open-label, multicenter, dose-escalation phase 1 study Int J Hematol. 2022 Dec;116(6):911-921. doi: 10.1007/s12185-022-03450-5. Epub 2022 Sep 15. PMID : 36107394
  33. Ri M, Suzuki K, Ishida T, Kuroda J, Tsukamoto T, Teshima T, Goto H, Jackson CC, Sun H, Pacaud L, Fujikawa E, Yeh TM, Hatayama T, Aida K, Sunagawa Y, Iida S. Ciltacabtagene autoleucel in patients with relapsed/refractory multiple myeloma: CARTITUDE-1 (phase 2) Japanese cohort Cancer Sci. 2022 Dec;113(12):4267-4276. doi: 10.1111/cas.15556. Epub 2022 Oct 7. PMID : 36052883
  34. Konuma T, Shimomura Y, Ishiyama K, Ara T, Nakamae H, Hiramoto N, Eto T, Maruyama Y, Nagafuji K, Ishikawa J, Uchida N, Tanaka M, Onizuka M, Ueda Y, Anzai N, Kimura T, Kanda Y, Fukuda T, Atsuta Y. Haploidentical transplantation with post-transplant cyclophosphamide versus single cord blood transplantation for myelodysplastic syndrome: A retrospective study from the Adult Myelodysplastic Syndrome Working Group of the Japanese Society for Transplantation and Cellular Therapy (JSTCT) Am J Hematol. 2022 Dec;97(12):E447-E450. doi: 10.1002/ajh.26722. Epub 2022 Sep 22. PMID : 36088638
  35. Morita-Fujita M, Arai Y, Kondo T, Harada K, Uchida N, Toya T, Ozawa Y, Fukuda T, Ota S, Onizuka M, Kanda Y, Maruyama Y, Takada S, Kawakita T, Ara T, Ichinohe T, Kimura T, Atsuta Y, Kako S. Adult patients with Ph+ ALL benefit from conditioning regimen of medium-dose VP16 plus CY/TBI Hematol Oncol. 2022 Dec;40(5):1041-1055. doi: 10.1002/hon.3046. Epub 2022 Jul 10. PMID : 35790020
  36. Okinaka K, Akeda Y, Inamoto Y, Fuji S, Ito A, Tanaka T, Kurosawa S, Kim SW, Tanosaki R, Yamashita T, Ohwada C, Kurata K, Mori T, Onozawa M, Takano K, Yokoyama H, Koh K, Nagafuji K, Nakayama K, Sakura T, Takahashi T, Oishi K, Fukuda T. Immunogenicity of three versus four doses of 13-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal polysaccharide vaccine in allogeneic haematopoietic stem cell transplantation recipients: a multicentre, randomized controlled trial Clin Microbiol Infect. 2022 Dec 8:S1198-743X(22)00611-5. doi: 10.1016/j.cmi.2022.12.007. Online ahead of print. PMID : 36503114
  37. Perl AE, Larson RA, Podoltsev NA, Strickland S, Wang ES, Atallah E, Schiller GJ, Martinelli G, Neubauer A, Sierra J, Montesinos P, Recher C, Yoon SS, Maeda Y, Hosono N, Onozawa M, Kato T, Kim HJ, Hasabou N, Nuthethi R, Tiu R, Levis MJ. Outcomes in Patients with FLT3-Mutated Relapsed/ Refractory Acute Myelogenous Leukemia Who Underwent Transplantation in the Phase 3 ADMIRAL Trial of Gilteritinib versus Salvage Chemotherapy Transplant Cell Ther. 2022 Dec 13:S2666-6367(22)01832-2. doi: 10.1016/j.jtct.2022.12.006. Online ahead of print. PMID : 36526260
  38. Shimomura Y, Kitamura T, Nishikubo M, Sobue T, Uchida N, Doki N, Tanaka M, Ito A, Ishikawa J, Ara T, Ota S, Onizuka M, Sawa M, Ozawa Y, Maruyama Y, Ikegame K, Kanda Y, Ichinohe T, Fukuda T, Okamoto S, Teshima T, Atsuta Y. Effect of the COVID-19 pandemic on allogeneic stem cell transplantation in Japan Int J Hematol. 2022 Dec 14:1-8. doi: 10.1007/s12185-022-03508-4. Online ahead of print. PMID : 36515796
  39. Yoshida S, Onozawa M, Miyashita N, Kimura H, Takahashi S, Yokoyama S, Matsukawa T, Hirabayashi S, Mori A, Hidaka D, Minauchi K, Shigematsu A, Hashiguchi J, Igarashi T, Kakinoki Y, Tsutsumi Y, Ibata M, Kobayashi H, Haseyama Y, Fujimoto K, Ishihara T, Sakai H, Ota S, Kondo T, Teshima T. Clinical features of complex karyotype in newly diagnosed acute myeloid leukemia Int J Hematol. 2022 Dec 26. doi: 10.1007/s12185-022-03522-6. Online ahead of print. PMID : 36572814
  40. Miyashita N, Ohashi K, Fujita M, Hosoda T, Kawasaki Y, Takimoto M, Onozawa M. Prognostic factors in patients in the terminal phase of haematological malignancies who are receiving home medical care Br J Haematol. 2022 Dec 26. doi: 10.1111/bjh.18623. Online ahead of print. PMID : 36572123
  41. Kato K, Makita S, Goto H, Kanda J, Fujii N, Shimada K, Akashi K, Izutsu K, Teshima T, Fukuda N, Sumitani T, Sumi H, Shimizu S, Kakurai Y, Yoshikawa K, Tobinai K, Usui N, Hatake K. Phase 2 study of axicabtagene ciloleucel in Japanese patients with relapsed or refractory large B-cell lymphoma Int J Clin Oncol. 2022 Jan;27(1):213-223. doi: 10.1007/s10147-021-02033-4. Epub 2021 Oct 1. PMID : 34599413
  42. Yoshida S, Ara T, Okada K, Mori Y, Tsukamoto S, Miyashita N, Kasahara K, Ebata K, Iwasaki J, Takahashi S, Shigematsu A, Minauchi K, Kobayashi N, Ogasawara M, Imamura M, Teshima T, Ota S. The preceding hyponatremia is a useful hallmark for the diagnosis of HHV-6 encephalitis after allogeneic hematopoietic stem cell transplantation Bone Marrow Transplant. 2023 Jan;58(1):97-99. doi: 10.1038/s41409-022-01843-y. Epub 2022 Oct 15. PMID : 36243759
  43. Kobayashi S, Kanda Y, Konuma T, Inamoto Y, Matsumoto K, Uchida N, Ikegame K, Miyamoto T, Doki N, Nakamae H, Katayama Y, Takahashi S, Shiratori S, Saito S, Kawakita T, Kanda J, Fukuda T, Atsuta Y, Kimura F. Outcomes of third allogeneic hematopoietic stem cell transplantation in relapsed/refractory acute leukemia after a second transplantation Bone Marrow Transplant. 2022 Jan;57(1):43-50. doi: 10.1038/s41409-021-01485-6. Epub 2021 Oct 8. PMID : 34625663
  44. Nakano K, Sugita J, Seimiya M, Yasuda K, Watanabe C, Goto H, Teshima T. IgG4-IgE complex interferes with measurement of IgE concentration Clin Biochem. 2023 Feb;112:11-16. doi: 10.1016/j.clinbiochem.2022.12.006. Epub 2022 Dec 9. PMID : 36509149
  45. Fowler NH, Dickinson M, Dreyling M, Martinez-Lopez J, Kolstad A, Butler J, Ghosh M, Popplewell L, Chavez JC, Bachy E, Kato K, Harigae H, Kersten MJ, Andreadis C, Riedell PA, Ho PJ, Pérez-Simón JA, Chen AI, Nastoupil LJ, von Tresckow B, Ferreri AJM, Teshima T, Patten PEM, McGuirk JP, Petzer AL, Offner F, Viardot A, Zinzani PL, Malladi R, Zia A, Awasthi R, Masood A, Anak O, Schuster SJ, Thieblemont C. Tisagenlecleucel in adult relapsed or refractory follicular lymphoma: the phase 2 ELARA trial Nat Med. 2022 Feb;28(2):325-332. doi: 10.1038/s41591-021-01622-0. Epub 2021 Dec 17. PMID : 34921238
  46. Mori A, Onozawa M, Hidaka D, Yokoyama S, Miyajima T, Yokoyama E, Ogasawara R, Izumiyama K, Saito M, Fujisawa S, Ota S, Kakinoki Y, Tsutsumi Y, Yamamoto S, Miyagishima T, Nagashima T, Iwasaki H, Kobayashi H, Haseyama Y, Kurosawa M, Morioka M, Teshima T, Kondo T. Non-age-related neoplastic loss of sex chromosome correlated with prolonged survival in real-world CBF-AML patients Int J Hematol. 2022 Feb;115(2):188-197. doi: 10.1007/s12185-021-03238-z. Epub 2021 Nov 5. PMID : 34739701
  47. Imahashi N, Terakura S, Kondo E, Kato K, Kim SW, Shinohara A, Watanabe M, Fukuda T, Uchida N, Kobayashi H, Ishikawa J, Kataoka K, Shiratori S, Ikeda T, Matsuoka KI, Yoshida S, Kondo T, Kimura T, Onizuka M, Ichinohe T, Atsuta Y, Kanda J. Impact of donor types on reduced-intensity conditioning allogeneic stem cell transplant for mature lymphoid malignancies Bone Marrow Transplant. 2022 Feb;57(2):243-251. doi: 10.1038/s41409-021-01525-1. Epub 2021 Nov 24. PMID : 34815519
  48. Miyao K, Kuwatsuka Y, Murata M, Nagafuji K, Teshima T, Takeuchi Y, Shiratori S, Najima Y, Uchida N, Tanaka M, Sawa M, Ota S, Fukuda T, Ozawa Y, Kako S, Kawakita T, Ara T, Tanaka J, Kanda Y, Atsuta Y, Kanda J, Terakura S; GVHD Working Group and Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Antithymocyte Globulin Potentially Could Overcome an Adverse Effect of Acute Graft-versus-Host Disease in Matched-Related Peripheral Blood Stem Cell Transplantation Transplant Cell Ther. 2022 Mar;28(3):153.e1-153.e11. doi: 10.1016/j.jtct.2021.12.009. Epub 2021 Dec 22. PMID : 34954151
  49. Harada K, Mizuno S, Yano S, Takami A, Ishii H, Ikegame K, Najima Y, Kako S, Ashida T, Shiratori S, Ota S, Onizuka M, Fukushima K, Fukuda T, Ichinohe T, Atsuta Y, Yanada M. Donor lymphocyte infusion after haploidentical hematopoietic stem cell transplantation for acute myeloid leukemia Ann Hematol. 2022 Mar;101(3):643-653. doi: 10.1007/s00277-021-04731-5. Epub 2022 Jan 6. PMID : 34988692
  50. Yoshimoto-Haramura T, Hidaka M, Hasegawa K, Suzumura K, Takemura N, Hama N, Mizuno T, Nomi T, Kobayashi T, Sano K, Yokomizo H, Nitta H, Kurata M, Hasegawa Y, Nagayama M, Tani M, Fukumoto T, Ohta M, Hayashi H, Taniguchi H, Ishino S, Aihara T, Murase T, Tsuchida A, Shimamura T, Marubashi S, Kaneko J, Hara T, Matsushima H, Soyama A, Endo T, Eguchi S. National survey of hepatobiliary and pancreatic surgery in hemophilia patients in Japan J Hepatobiliary Pancreat Sci. 2022 Mar;29(3):385-393. doi: 10.1002/jhbp.1073. Epub 2021 Nov 17. PMID : 34726831
  51. Mori A, Onozawa M, Tsukamoto S, Ishio T, Yokoyama E, Izumiyama K, Saito M, Muraki H, Morioka M, Teshima T, Kondo T. Humoral response to mRNA-based COVID-19 vaccine in patients with myeloid malignancies Br J Haematol. 2022 Jun;197(6):691-696. doi: 10.1111/bjh.18138. Epub 2022 Mar 14. PMID : 35226358
  52. Harada S, Onozawa M, Hidaka D, Yokoyama S, Senjo H, Takahashi S, Ogasawara R, Kanaya M, Mori A, Ota S, Kondo T, Teshima T. Dynamic change in peripheral blood WT1 mRNA levels within three cycles of azacitidine predict treatment response in patients with high-risk myelodysplastic syndromes Ann Hematol. 2022 Jun;101(6):1239-1250. doi: 10.1007/s00277-022-04807-w. Epub 2022 Mar 8. PMID : 35257209
  53. Sekiguchi N, Rai S, Munakata W, Suzuki K, Handa H, Shibayama H, Endo T, Terui Y, Iwaki N, Fukuhara N, Tatetsu H, Iida S, Ishikawa T, Iguchi D, Izutsu K. Two-year outcomes of tirabrutinib monotherapy in Waldenström's macroglobulinemia Cancer Sci. 2022 Jun;113(6):2085-2096. doi: 10.1111/cas.15344. Epub 2022 Apr 6. PMID : 35332633
  54. Nishida M, Sugita J, Iwai T, Sato M, Kudo Y, Omotehara S, Horie T, Sakano R, Hasegawa Y, Yasumoto A, Cho Y, Teshima T. Ultrasonographic scoring system of late-onset sinusoidal obstruction syndrome/veno-occlusive disease after hematopoietic stem cell transplantation Bone Marrow Transplant. 2022 Aug;57(8):1338-1340. doi: 10.1038/s41409-022-01717-3. Epub 2022 May 25. PMID : 35614317
  55. Tamai M, Fujisawa S, Nguyen TTT, Komatsu C, Kagami K, Kamimoto K, Omachi K, Kasai S, Harama D, Watanabe A, Akahane K, Goi K, Naka K, Kaname T, Teshima T, Inukai T. Creation of Philadelphia chromosome by CRISPR/Cas9-mediated double cleavages on BCR and ABL1 genes as a model for initial event in leukemogenesis Cancer Gene Ther. 2022 Aug 23. doi: 10.1038/s41417-022-00522-w. Online ahead of print. PMID : 35999358
  56. Shiratori S, Okada K, Matsuoka S, Ito S, Sugita J, Teshima T. Serum levels of albumin and creatinine predict the outcome of sinusoidal obstruction syndrome after allogeneic HSCT Ann Hematol. 2022 Sep;101(9):2117-2118. doi: 10.1007/s00277-022-04886-9. Epub 2022 Jun 20. PMID : 35723710
  57. Iida S, Ishida T, Miyamoto T, Teramukai S, Shirai H, Kanamori R, Tajima Y, Crawford B, Yi J, Teshima T. MEdical Database AnaLysIS of Japanese multiple myeloma patienTs with apheresis #2 (MEDALIST-2): the impact of plerixafor use on costs and healthcare resources during mobilization and stem cell transplantation Int J Hematol. 2022 Sep;116(3):411-422. doi: 10.1007/s12185-022-03356-2. Epub 2022 May 13. PMID : 35551631
  58. Saliba RM, Alousi AM, Pidala J, Arora M, Spellman SR, Hemmer MT, Wang T, Abboud C, Ahmed S, Antin JH, Beitinjaneh A, Buchbinder D, Byrne M, Cahn JY, Choe H, Hanna R, Hematti P, Kamble RT, Kitko CL, Laughlin M, Lekakis L, MacMillan ML, Martino R, Mehta PA, Nishihori T, Patel SS, Perales MA, Rangarajan HG, Ringdén O, Rosenthal J, Savani BN, Schultz KR, Seo S, Teshima T, van der Poel M, Verdonck LF, Weisdorf D, Wirk B, Yared JA, Schriber J, Champlin RE, Ciurea SO. Characteristics of Graft-Versus-Host Disease (GvHD) After Post-Transplantation Cyclophosphamide Versus Conventional GvHD Prophylaxis Transplant Cell Ther. 2022 Oct;28(10):681-693. doi: 10.1016/j.jtct.2022.07.013. Epub 2022 Jul 16. PMID : 35853610
  59. Benjamin R, Jain N, Maus MV, Boissel N, Graham C, Jozwik A, Yallop D, Konopleva M, Frigault MJ, Teshima T, Kato K, Boucaud F, Balandraud S, Gianella-Borradori A, Binlich F, Marchiq I, Dupouy S, Almena-Carrasco M, Pannaux M, Fouliard S, Brissot E, Mohty M; CALM Study Group. UCART19, a first-in-class allogeneic anti-CD19 chimeric antigen receptor T-cell therapy for adults with relapsed or refractory B-cell acute lymphoblastic leukaemia (CALM): a phase 1, dose-escalation trial Lancet Haematol. 2022 Nov;9(11):e833-e843. doi: 10.1016/S2352-3026(22)00245-9. Epub 2022 Oct 10. PMID : 36228643
  60. Murakami K, Iwasaki S, Oguri S, Tanaka K, Suzuki R, Hayasaka K, Fujisawa S, Watanabe C, Konno S, Yokota I, Fukuhara T, Murakami M, Teshima T. SARS-CoV-2 Omicron detection by antigen tests using saliva J Clin Virol Plus. 2022 Nov;2(4):100109. doi: 10.1016/j.jcvp.2022.100109. Epub 2022 Sep 13. PMID : 36118305
  61. Sugita J, Atsuta Y, Nakamae H, Maruyama Y, Ishiyama K, Shiratori S, Fukuda T, Kurata M, Shingai N, Ozawa Y, Masuko M, Nagafuji K, Uchida N, Tanaka M, Onizuka M, Kanda J, Kimura T, Ichinohe T, Teshima T. Comparable survival outcomes with haploidentical stem cell transplantation and cord blood transplantation Bone Marrow Transplant. 2022 Nov;57(11):1681-1688. doi: 10.1038/s41409-022-01770-y. Epub 2022 Aug 20. PMID : 35987912
  62. Dertschnig S, Gergely P, Finke J, Schanz U, Holler E, Holtick U, Socié G, Medinger M, Passweg J, Teshima T, Stylianou C, Oehen S, Heim D, Bucher C. Mocravimod, a Selective Sphingosine-1-Phosphate Receptor Modulator, in Allogeneic Hematopoietic Stem Cell Transplantation for Malignancy Transplant Cell Ther. 2022 Nov 4:S2666-6367(22)01741-9. doi: 10.1016/j.jtct.2022.10.029. Online ahead of print. PMID : 36343893
  63. Iwai T, Nishida M, Sugita J, Yasumoto A, Hasegawa Y, Morimoto T, Nakayama D, Okada K, Mori A, Teshima T. Ultrasonographic monitoring of sinusoidal obstruction syndrome in patients treated with inotuzumab ozogamicin Int J Hematol. 2022 Dec;116(6):973-975. doi: 10.1007/s12185-022-03477-8. Epub 2022 Oct 29. PMID : 36308679
  64. Atsuta Y, Sugita J, Nakamae H, Maruyama Y, Ishiyama K, Shiratori S, Fukuda T, Kurata M, Shingai N, Ozawa Y, Masuko M, Nagafuji K, Takada S, Kako S, Kanda Y, Kanda J, Ichinohe T, Teshima T. Comparable survival outcomes with haploidentical stem cell transplantation and unrelated bone marrow transplantation Bone Marrow Transplant. 2022 Dec;57(12):1781-1787. doi: 10.1038/s41409-022-01822-3. Epub 2022 Sep 12. PMID : 36097040

英文症例報告

  1. Mizushima M, Sugiyama T, Eguchi K, Tarisawa M, Tokairin K, Ito M, Hashimoto D, Yabe I, Fujimura M. Rescue Extracranial-Intracranial Bypass for Ischemic Stroke Secondary to Progressive Human Immunodeficiency Virus-Associated Vasculopathy J Neurol Surg A Cent Eur Neurosurg. 2022 Feb 22. doi: 10.1055/a-1779-4142. Online ahead of print. PMID : 35193153
  2. Nakano K, Sugita J, Mafune N, Seimiya M, Yasuda K, Watanabe C, Teshima T. IgG4-IgE complex in a patient with IgG4-related disease Clin Chim Acta. 2022 Mar 1;528:52-55. doi: 10.1016/j.cca.2022.01.013. Epub 2022 Jan 20. PMID : 35065908
  3. Nakano K, Sugita J, Seimiya M, Yasuda K, Watanabe C, Teshima T. IgG4-IgE complex in patients with IgG4-related disease Clin Chim Acta. 2022 Jun 1;531:261-264. doi: 10.1016/j.cca.2022.04.013. Epub 2022 Apr 18. PMID : 35439534
  4. Ara T, Endo T, Goto H, Kasahara K, Hasegawa Y, Yokoyama S, Shiratori S, Nakagawa M, Kuwahara K, Takakuwa E, Hashino S, Teshima T. Antiretroviral therapy achieved metabolic complete remission of hepatic AIDS related Epstein-Barr virus-associated smooth muscle tumor Antivir Ther. 2022 Oct;27(5):13596535221126828. doi: 10.1177/13596535221126828. PMID : 36112852
  5. Tsutsumi Y, Ito S, Kobayashi M, Teshima T. A Rare Case of BCL2-Positive Multiple Myeloma Complicated with Follicular Lymphoma Case Rep Hematol. 2022 Oct 3;2022:3076968. doi: 10.1155/2022/3076968. eCollection 2022. PMID : 36225194
  6. Miyajima T, Ohigashi H, Yaguchi H, Teshima T. Neurolymphomatosis in Intravascular Large B-cell Lymphoma Intern Med. 2022 Oct 5. doi: 10.2169/internalmedicine.0021-22. Online ahead of print. PMID : 36198588
  7. Fukushima A, Iwasaki K, Hishimura R, Matsubara S, Joutoku Z, Matsuoka M, Endo T, Onodera T, Kondo E, Iwasaki N. Three-stage total knee arthroplasty combined with deformity correction and leg lengthening using Taylor spatial frames and conversion to internal fixation for severe intra- and extra-articular deformities and hypoplasia in a patient with hemophilic knee arthropathy: A case report Knee. 2022 Nov 18;40:90-96. doi: 10.1016/j.knee.2022.10.009. Online ahead of print. PMID : 36410255
  8. Miyashita N, Onozawa M, Suto K, Fujisawa S, Okazaki N, Hidaka D, Ohigashi H, Yasumoto A, Sugita J, Hashimoto D, Matsuno Y, Teshima T. Aleukemic Extramedullary Blast Crisis as an Initial Presentation of Chronic Myeloid Leukemia with E1A3 BCR-ABL1 Fusion Transcript Intern Med. 2022 Apr 1;61(7):1049-1054. doi: 10.2169/internalmedicine.8319-21. Epub 2021 Sep 11. PMID : 34511573
  9. Miyajima T, Hasegawa Y, Hashimoto D, Teshima T. Unilateral recurrent laryngeal nerve palsy detected by PET/CT in a patient with mediastinal T-cell lymphoblastic lymphoma Int J Hematol. 2022 Jul;116(1):3-4. doi: 10.1007/s12185-022-03395-9. Epub 2022 May 27. PMID : 35622297

英文著書

  1. Akahoshi Y, Kimura SI, Tada Y, Matsukawa T, Tamaki M, Doki N, Uchida N, Tanaka M, Nakamae H, Kuriyama T, Matsuoka KI, Ikeda T, Kimura T, Fukuda T, Kanda Y, Atsuta Y, Murata M, Terakura S, Nakasone H. Cytomegalovirus gastroenteritis in patients with acute graft-versus-host disease Blood Adv. 2022 Jan 25;6(2):574-584. doi: 10.1182/bloodadvances.2021005885. PMID : 34788389
  2. Matsukawa T, Yin M, Baslan T, Chung YJ, Cao D, Bertoli R, Zhu YJ, Walker RL, Freeland A, Knudsen E, Lowe SW, Meltzer PS, Aplan PD. Mcm2 hypomorph leads to acute leukemia or hematopoietic stem cell failure, dependent on genetic context FASEB J. 2022 Sep;36(9):e22430. doi: 10.1096/fj.202200061RR. PMID : 35920299

和文総説

  1. 造血幹細胞移植療法の現状と未来(解説)
    Author： 豊嶋 崇徳(北海道大学 大学院医学研究院血液内科)
    Source： 日本内科学会雑誌(0021-5384)111巻9号 Page1938-1943(2022.09)
     
  2. 古典的急性GVHD(Nonclassical acute GVHD)(解説)
    Author： 豊嶋 崇徳(北海道大学 大学院医学研究院血液内科学)
    Source： 血液内科(2185-582X)85巻3号 Page379-383(2022.09)
     
  3. 【血液疾患のすべて】治療　造血幹細胞移植(解説)
    Author： 豊嶋 崇徳(北海道大学 大学院医学研究院血液内科学)
    Source： 日本医師会雑誌(0021-4493)151巻特別1 Page S168-S170(2022.06)
     
  4. 血液がん治療とサイトカインストーム.
    Author： 豊嶋崇徳
    Source： BIO EX-press 2022冬: 24-27, 2022.
     
  5. 遺伝子改変T細胞(CAR-T)療法. 
    Author： 豊嶋崇徳
    Source： 日本内科学会雑誌 110(3): 414-419, 2022.
     
  6. 血液がんの最新治療！CAR-T細胞療法. 
    Author： 豊嶋崇徳
    Source： NHKきょうの健康　12月号 No.417 : 72-75, 2022.
     
  7. GVHDの病態生理と新規治療薬
    Author： 荒 隆英, 橋本 大吾
    Source： 臨床血液. 2022;63(9):1261-1269. doi: 10.11406/rinketsu.63.1261
     
  8. GVHDによる生体恒常性維持機構の破綻
    Author： 荒 隆英, 橋本 大吾
    Source： 日本造血・免疫細胞療法学会雑誌. 2022 年 11 巻 2 号 p. 90-100. doi: 10.7889/tct-22-001
     
  9. 【層別化される悪性リンパ腫の病態と診療】未分化大細胞リンパ腫の病態と治療の考え方(解説)
    Author： 中川雅夫  (北大 大学院医学研究科 内科系部門 内科学分野 血液内科)  
    Source： 血液内科(2185-582X)84巻3号 Page345-350(2022.03)
     
  10. 成人T細胞性白血病リンパ腫の治療標的としてのCDK6(解説)
    Author： 石尾 崇(北海道大学 大学院医学研究院内科系部門内科学分野血液内科学教室), 中川 雅夫
    Source： 血液内科(2185-582X)85巻1号 Page84-88(2022.07)
     
  11. 多発性骨髄腫におけるCAR-T細胞療法の展開 
    Author： 後藤 秀樹
    Source： 臨床血液 63(6) 580-588 2022
     
  12. 【臨床血液学2022-血液疾患診療の注目すべき進歩と将来像(造血幹細胞移植)-】抗胸腺細胞グロブリンを用いたGVHD予防法の変遷・現状・未来(解説)
    Author： 白鳥 聡一(北海道大学 大学院医学研究院血液内科学分野)
    Source： 臨床血液(0485-1439)63巻5号 Page412-422(2022.05)

和文症例報告

  1. Gilteritinibが奏効したFLT3-N676K変異を有する再発急性骨髄性白血病(原著論文)
    Author： 宮島 徹(愛育病院 血液病センター), 原田 晋平, 小笠原 励起, 横山 絵美, 泉山 康, 盛 暁生, 齋藤 誠, 森岡 正信, 池 成基, 南 陽介, 近藤 健
    Source： 臨床血液(0485-1439)63巻1号 Page51-54(2022.01)

和文原著

  1. 尿沈渣中にヘマトイジン結晶を継続的に認めた1症例(原著論文)
    Author： 猪股 百華(北海道大学病院 検査・輸血部), 志賀 麻衣子, 小林 美穂, 山下 亜妃子, 渡邊 千秋, 杉田 純一, 豊嶋 崇徳
    Source： 医学検査(0915-8669)71巻4号 Page743-747(2022.10)
     
  2. 移植後ウイルス性出血性膀胱炎の診断と予後改善への尿沈渣検査の活用(原著論文)
    Author： 志賀 麻衣子(北海道大学病院 検査・輸血部), 眞船 直樹, 杉田 純一, 豊嶋 崇徳
    Source： 日本臨床検査医学会誌(2436-2727)70巻2号 Page106-110(2022.02)
     
  3. Tirabrutinibが奏効したBing-Neel症候群(原著論文)
    Author： 横山 慶人(北海道大学 大学院医学研究院血液内科), 大東 寛幸, 宮島 徹, 宮下 直樹, 岡田 怜, 長谷川 祐太, 杉田 純一, 小野澤 真弘, 橋本 大吾, 豊嶋 崇徳
    Source： 臨床血液(0485-1439)63巻8号 Page870-875(2022.08)
     
  4. HIV関連悪性リンパ腫の臨床的特徴
    Author： 遠藤 知之, 後藤 秀樹, 荒 隆英, 長谷川 祐太, 横山 翔大, 高橋 承吾, 米田 和樹, 橋本 大吾, 橋野 聡, 豊嶋 崇徳
    Source： 日本エイズ学会誌 2022年4巻1号 Page13-20
     
  5. CAR-T細胞療法関連の血液毒性(解説)
    Author： 後藤 秀樹(北海道大学病院 血液内科)
    Source： 血液内科(2185-582X)85巻2号 Page248-252(2022.08)
     
  6. 【多発性骨髄腫および類縁疾患の病態解析と治療の進歩】多発性骨髄腫に対するCAR-T細胞療法の現状と課題(解説)"
    Author： 後藤 秀樹(北海道大学病院 血液内科)
    Source： 血液内科(2185-582X)84巻4号 Page525-531(2022.04)

和文著書

  1. <雑誌> 豊嶋崇徳(分担執筆)
    誌名： EBM血液疾患の治療2023-2024
    Title： 新型コロナウイルス感染症流行下における造血器腫瘍の治療 2022年10月
     
  2. <雑誌> 豊嶋崇徳（編集）
    誌名： 別冊・医学のあゆみ
    Title： CAR-T細胞治療法の現在と将来展望 2022年4月
     
  3. <雑誌> 遠藤知之　他12名
    誌名： 抗HIV治療ガイドライン
    Title： 急性HIV感染症とその治療 2022年3月
     
  4. <書名> 遠藤知之　他22名
    誌名： HIV感染症｢治療の手引き｣
    Title： 2022年11月
     
  5. <教科書> 小野澤真弘
    誌名： EBM血液疾患の治療2023-2024 
    Title： 造血幹細胞移植後のB型肝炎ウイルス対策 2022年10月
     
  6. <雑誌> 後藤秀樹
    誌名： 日本医事新報
    Title： 悪性リンパ腫へのCAR-T細胞療法のコツは？ 2022年10月
     
  7. <雑誌> 後藤秀樹
    誌名： Precision Medicine
    Title： B細胞リンパ腫に対するCAR-T細胞療法  2022年9月
     
  8. <書名> 後藤秀樹
    誌名： がん治療の薬理学
    Title： 免疫チェックポイント阻害薬、がんワクチン、CAR-T療法、二重特異性抗体  2022年3月